Holen Sie sich die Stockscreener-App
4.465
28.33%
-1.765
Handel nachbörslich:
4.53
0.065
+1.46%
Schlusskurs vom Vortag:
$6.23
Offen:
$3.9
24-Stunden-Volumen:
6.68M
Relative Volume:
16.06
Marktkapitalisierung:
$282.07M
Einnahmen:
$198.53M
Nettoeinkommen (Verlust:
$-63.68M
KGV:
-4.368
EPS:
-1.0222
Netto-Cashflow:
$-41.50M
1W Leistung:
-30.13%
1M Leistung:
-25.58%
6M Leistung:
-37.99%
1J Leistung:
-43.48%
1-Tages-Spanne:
$3.4006
$4.5014
1-Wochen-Bereich:
$3.4006
$6.65
52-Wochen-Spanne:
$3.4006
$10.79
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Firmenname
Treace Medical Concepts Inc
Sektor
Branche
Telefon
(904) 373-5940
Adresse
100 PALMETTO PARK PLACE, PONTE VEDRA
Vergleichen Sie TMCI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.465 | 393.57M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
126.36 | 217.27B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.02 | 146.84B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
356.03 | 135.31B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
92.20 | 115.51B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
83.39 | 47.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-04 | Hochstufung | BTIG Research | Neutral → Buy |
| 2024-12-31 | Eingeleitet | Lake Street | Buy |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-05-16 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-08 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-05-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-08 | Herabstufung | Truist | Buy → Hold |
| 2023-09-29 | Eingeleitet | UBS | Buy |
| 2023-05-01 | Eingeleitet | Truist | Buy |
| 2023-04-11 | Eingeleitet | Stephens | Equal-Weight |
| 2022-05-12 | Eingeleitet | BTIG Research | Buy |
| 2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-18 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Eingeleitet | SVB Leerink | Outperform |
| 2021-05-18 | Eingeleitet | Stifel | Buy |
Alle ansehen
Treace Medical Concepts Inc Aktie (TMCI) Neueste Nachrichten
Treace Medical’s Earnings Call: Growth Amid Challenges - TipRanks
UBS Group Cuts Treace Medical Concepts (NASDAQ:TMCI) Price Target to $5.85 - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Receives "Underweight" Rating from JPMorgan Chase & Co. - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Receives Neutral Rating from BTIG Research - MarketBeat
Is Treace Medical Concepts (NASDAQ:TMCI) Using Too Much Debt? - simplywall.st
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Q3 2025 Earnings Call Transcript - Insider Monkey
Is Treace Medical Concepts Inc. stock poised for growthJuly 2025 Analyst Calls & Community Verified Swing Trade Signals - newser.com
Treace Medical Concepts (NASDAQ:TMCI) Lowered to Sell Rating by Wall Street Zen - MarketBeat
Treace Medical Concepts (NASDAQ:TMCI) Releases Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
UBS Maintains Treace Medical Concepts (TMCI) Neutral Recommendation - Nasdaq
Treace Medical Concepts Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Treace Medical revises 2025 revenue guidance to $211M-$213M as demand shifts and new products expand market reach - MSN
Treace Medical Concepts stock downgraded to Neutral by BTIG on weak outlook - Investing.com South Africa
Treace Medical down after Q3; BTIG downgrades (TMCI:NASDAQ) - Seeking Alpha
Transcript : Treace Medical Concepts, Inc., Q3 2025 Earnings Call, Nov 06, 2025 - MarketScreener
Treace Medical (TMCI) Q3 2025 Earnings Transcript - The Motley Fool
UBS Adjusts Price Target on Treace Medical Concepts to $5.85 From $6.50, Maintains Neutral Rating - MarketScreener
Will Treace Medical Concepts Inc. price bounce be sustainableWeekly Stock Recap & Free Community Consensus Stock Picks - newser.com
Is it time to cut losses on Treace Medical Concepts Inc.Trade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Treace Announces Participation in Two Upcoming Investor Conferences - The Manila Times
Treace (NASDAQ: TMCI) sets Nov 10 UBS fireside chat at 11:45 am ET; Stifel participation - Stock Titan
JPMorgan Downgrades Treace Medical Concepts to Underweight From Neutral, Adjusts PT to $5 From $8 - MarketScreener
BTIG Research Downgrades Treace Medical Concepts to Neutral From Buy - MarketScreener
Treace Medical Concepts Inc (TMCI) Q3 2025 Earnings Call Highlights: Revenue Growth Amidst ... By GuruFocus - Investing.com Canada
JPMorgan downgrades Treace Medical stock rating to Underweight amid market headwinds - Investing.com Australia
JPMorgan downgrades Treace Medical stock rating to Underweight amid market headwinds By Investing.com - Investing.com South Africa
Treace Medical Concepts: Q3 Earnings Snapshot - theheraldreview.com
Earnings call transcript: Treace Medical Q3 2025 reveals revenue growth By Investing.com - Investing.com Philippines
Treace Medical Concepts Reports Q3 2025 Financial Results - TipRanks
Earnings call transcript: Treace Medical Q3 2025 reveals revenue growth - Investing.com
Treace Medical Concepts (TMCI) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Treace Medical Concepts, Inc. (TMCI) Q3 FY2025 earnings call transcript - Yahoo Finance
Treace Medical Concepts Reports Third Quarter 2025 Financial Results - The Manila Times
Treace Medical Concepts Inc.’s volatility index tracking explainedWeekly Gains Report & Community Verified Trade Alerts - newser.com
Volume spikes in Treace Medical Concepts Inc. stock – what they meanQuarterly Portfolio Review & High Conviction Trade Alerts - newser.com
Why Treace Medical Concepts Inc. stock could be next big winnerNew Guidance & Reliable Price Breakout Alerts - newser.com
Why Treace Medical Concepts Inc. stock could benefit from AI revolutionJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com
What catalysts could drive Treace Medical Concepts Inc. stock higherWeekly Volume Report & Capital Protection Trading Alerts - newser.com
Real time social sentiment graph for Treace Medical Concepts Inc.2025 Year in Review & Real-Time Stock Entry Alerts - newser.com
Developing predictive dashboards with Treace Medical Concepts Inc. dataEarnings Performance Report & Growth-Oriented Investment Plans - newser.com
Price momentum metrics for Treace Medical Concepts Inc. explainedWeekly Profit Summary & Stepwise Trade Execution Plans - newser.com
What To Expect From Treace Medical Concepts Inc (TMCI) Q3 2025 E - GuruFocus
What To Expect From Treace Medical Concepts Inc (TMCI) Q3 2025 Earnings - Yahoo Finance
Should you wait for a breakout in Treace Medical Concepts Inc.July 2025 Institutional & Momentum Based Trading Ideas - newser.com
Published on: 2025-11-05 04:30:33 - newser.com
Can trapped investors hope for a rebound in Treace Medical Concepts Inc.July 2025 Catalysts & Community Consensus Stock Picks - newser.com
Published on: 2025-11-05 00:33:57 - newser.com
Treace Medical Concepts Inc expected to post a loss of 28 cents a shareEarnings Preview - TradingView
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medical Concepts, Inc. (TMCI) And Encourages Investors to Connect - ACCESS Newswire
Finanzdaten der Treace Medical Concepts Inc-Aktie (TMCI)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.21%
1.43%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):